Jason A Keyes - Net Worth and Insider Trading
Jason A Keyes Net Worth
The estimated net worth of Jason A Keyes is at least $321,509 dollars as of 2026-09-11. Jason A Keyes is the CFO of Equillium Inc and owns about 126,633 shares of Equillium Inc (EQ) stock worth over $306,452. Jason A Keyes is also the CFO of BlossomHill Therapeutics Inc and owns about 700 shares of BlossomHill Therapeutics Inc (BLSM) stock worth over $15,057. Details can be seen in Jason A Keyes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jason A Keyes has not made any transactions after 2026-08-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jason A Keyes
Jason A Keyes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jason A Keyes owns 6 companies in total, including Equillium Inc (EQ) , Sesen Bio Inc (SESN) , and Orexigen Therapeutics Inc (OREXQ) among others .
Click here to see the complete history of Jason A Keyes’s form 4 insider trades.
Insider Ownership Summary of Jason A Keyes
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| EQ | Equillium Inc | 2025-01-23 | Chief Financial Officer |
| SESN | Sesen Bio Inc | 2020-02-24 | director |
| OREXQ | Orexigen Therapeutics Inc | 2017-10-13 | EVP & Chief Financial Officer |
 | | 2020-02-24 | director |
| | 2024-08-12 | director |
| | 2026-08-06 | Chief Financial Officer |
Jason A Keyes Latest Holdings Summary
Jason A Keyes currently owns a total of 2 stocks. Among these stocks, Jason A Keyes owns 126,633 shares of Equillium Inc (EQ) as of January 23, 2025, with a value of $306,452 and a weighting of 95.32%. Jason A Keyes also owns 700 shares of BlossomHill Therapeutics Inc (BLSM) as of August 10, 2026, with a value of $15,057 and a weighting of 4.68%.
Latest Holdings of Jason A Keyes
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EQ | Equillium Inc | 2025-01-23 | 126,633 | 2.42 | 306,452 |
| BLSM | BlossomHill Therapeutics Inc | 2026-08-10 | 700 | 21.51 | 15,057 |
Holding Weightings of Jason A Keyes
Jason A Keyes Form 4 Trading Tracker
According to the SEC Form 4 filings, Jason A Keyes has made a total of 9 transactions in Equillium Inc (EQ) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Equillium Inc is the sale of 10,000 shares on January 23, 2025, which brought Jason A Keyes around $6,500.
According to the SEC Form 4 filings, Jason A Keyes has made a total of 1 transactions in BlossomHill Therapeutics Inc (BLSM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in BlossomHill Therapeutics Inc is the acquisition of 700 shares on August 10, 2026, which cost Jason A Keyes around $11,200.
Insider Trading History of Jason A Keyes
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Jason A Keyes Trading Performance
GuruFocus tracks the stock performance after each of Jason A Keyes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jason A Keyes is %. GuruFocus also compares Jason A Keyes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jason A Keyes within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jason A Keyes's insider trading performs compared to the benchmark.
Performance of Jason A Keyes
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 37.65 | | | | | |
| Relative Return to S&P 500(%) | 39.16 | | | | | |
Jason A Keyes Ownership Network
Ownership Network List of Jason A Keyes
Ownership Network Relation of Jason A Keyes
Jason A Keyes Owned Company Details
What does Equillium Inc do?
Who are the key executives at Equillium Inc?
Jason A Keyes is the Chief Financial Officer of Equillium Inc. Other key executives at Equillium Inc include director & Chief Scientific Officer Stephen Connelly , Sr. Vice President and COO Christine Zedelmayer , and Principal Accounting Officer Penny Tom .
Equillium Inc (EQ) Insider Trades Summary
Over the past 18 months, Jason A Keyes made no insider transaction in Equillium Inc (EQ). Other recent insider transactions involving Equillium Inc (EQ) include a net sale of 927,624 shares made by Christine Zedelmayer , a net sale of 71,533 shares made by Penny Tom , and a net sale of 230,975 shares made by Stephen Connelly .
In summary, during the past 3 months, insiders sold 0 shares of Equillium Inc (EQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,230,132 shares of Equillium Inc (EQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,230,132 shares.
Equillium Inc (EQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Equillium Inc Insider Transactions
Jason A Keyes Mailing Address
Above is the net worth, insider trading, and ownership report for Jason A Keyes. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jason A Keyes's mailing address is: San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
